G01N 2333/8114
Kunitz type inhibitors
G01N2333/8114 (Kunitz type inhibitors) appears on 36 US grants and 33 published applications in this corpus.
Search patents in G01N- Granted patents
- 36
- Published applications
- 33
- Assignees
- 31
- Inventors
- 81
- Latest grant
- 24 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 3 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 3 |
| 2008 | 2 | 1 |
| 2009 | 1 | 2 |
| 2010 | 1 | 2 |
| 2011 | 2 | 1 |
| 2012 | 2 | 3 |
| 2013 | 1 | 1 |
| 2014 | 3 | 1 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 3 |
| 2018 | 1 | 1 |
| 2019 | 2 | 3 |
| 2020 | 0 | 1 |
| 2021 | 3 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- TFPI inhibitors and methods of use24 Oct 2023US 11,793,855 B2Takeda Pharmaceutical Company Limited
- Blood collection tube, reagent, and method for analyzing blood characteristics using same25 Oct 2022US 11,480,559 B2Fujimori Kogyo Co., Ltd.
- Method and reagent for detecting ovarian clear cell adenocarcinoma7 Dec 2021US 11,193,936 B2Public University Corporation Yokohama City University
- Lung cancer markers and uses thereof31 Aug 2021US 11,105,806 B2Celera Corporation
- Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy30 Mar 2021US 10,960,048 B2Guard Therapeutics International AB
- Method and reagent for detecting pancreatic cancers13 Jul 2023US 2023/0221322 A1Public University Corporation Yokohama City University
- Method and reagent for detecting malignant ovarian tumors20 Apr 2023US 2023/0122642 A1Public University Corporation Yokohama City University
- Circulating fgfbp-1 (fibroblast growth factor-binding pro-tein 1) in the assessment of atrial fibrillation and for the prediction of stroke5 Aug 2021US 2021/0239712 A1Academisch Zickenhuis Maastricht
- Circulating tfpi-2 (tissue factor pathway inhibitor 2) in the assessment of atrial fibrillation and anticoagulation therapy17 Jun 2021US 2021/0181211 A1Academisch Zickenhuis Maastricht
- Lung cancer markers and uses thereof27 Feb 2020US 2020/0064347 A1Celera Corporation
Most cited
By later US patents
- Kallikrein-binding "Kunitz domain" proteins and analogues thereof50US 6,057,287 ADyax Corp. · 2000
- Method for performing activated clotting time test with reduced sensitivity to the presence of aprotinin and for assessing aprotinin sensitivity48US 6,632,678 B2Sienco, Inc. · 2003
- Method and kit for the early detection of impaired renal status37US 7,662,578 B2Children's Hospital Medical Center · 2010
- Method and reagent for determining biologically active heparin in plasma27US 4,234,682 ABoehringer Mannheim GmbH · 1980
- Kallikrein-binding “Kunitz domain” proteins and analogues thereof26US 7,628,983 B2Dyax Corp. · 2009